Last update 01 Nov 2024

Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.

Private Company|
2019|
Shanghai Shi, China

Overview

Tags

Other Diseases
Congenital Disorders
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease2
Nervous System Diseases2
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
DAG1(Dystroglycan)1
Cu x HIF-1α1
SOAT1(Acyl coenzyme A:cholesterol acyltransferase 1)1

Related

3
Drugs associated with Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.
Ataluren
Target
DAG1
Mechanism
Dystroglycan stimulants
Active Org.
PTC Therapeutics International Ltd. [+6]
Originator Org.
PTC Therapeutics, Inc.PTC Therapeutics, Inc.
Active Indication
Muscular Dystrophy, Duchenne
Inactive Indication
Aniridia [+9]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date31 Jul 2014
Trientine Hydrochloride
Target
Cu x HIF-1α
Mechanism
Cu modulators [+1]
Active Org.
INNOLIFE CO., LTD.INNOLIFE CO., LTD. [+9]
Originator Org.
Bausch Health Americas, Inc.
Active Indication
Hepatolenticular Degeneration [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date08 Nov 1985
Mitotane
Target
SOAT1
Mechanism
SOAT1 inhibitors
Active Org.
HRA Pharma Rare Diseases SAS [+3]
Originator Org.
Bristol Myers Squibb Co.Bristol Myers Squibb Co.
Active Indication
Cushing Syndrome [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date08 Jul 1970
100 Clinical Results associated with Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
100 Deals associated with Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiedi Pharmaceutical Technology (Shanghai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
2
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Mitotane
 ( SOAT1 )		Adrenocortical Carcinoma
More
Approved
Ataluren
 ( DAG1 )		Muscular Dystrophy, Duchenne
More
NDA/BLA
Trientine Hydrochloride
 ( Cu x HIF-1α )		Hepatolenticular Degeneration
More
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free